Genmab Announces Responses With HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
12th Dec 2005, 19:17 GMT
Genmab A/S announced preliminary results in the Phase II study using HuMax-CD4 to treat patients with refractory or relapsed non-cutaneous T-cell lymphoma.
Genmab Announces Responses With HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma related news:
- Genmab gibt Reaktionen mit HuMax-CD4(TM) bei nicht-kutanem T-Zell-Lymphom bekannt — Presseportal
- Transgene Releases Positive Phase I/II Data of TG1042 and Plans For a Pivotal Study in Cutaneous B-Cell Lymphoma — Laboratory News from StratCenter.com
- Transgene releases positive Phase I/II data of TG1042 (Ad-IFNg) and plans for a pivotal study in cutaneous b-cell lymphoma — ArriveNet : Business
- HuMax-CD38 erweist sich in vorklinischen Studien als effektiv — Presseportal.de Wirtschaft
- HuMax-CD20 ruft schnelles Ansprechen bei rezidiven CLL-Patienten hervor — Presseportal.de Finanzen
- Tositumomab Plus Stem Cell Transplant Induces Remission in Refractory B-Cell Lymphoma — Medscape Headlines
- Humax announces non-TiVo LCD TV/PVR combo for USA — PVR Wire
- Volume 193, number 2: Immunologic Response to Antiretroviral Therapy in Hepatitis C Virus-Coinfected Adults in a Population-Based HIV/AIDS Treatment Program — J Infect Dis Latest Issue
- Volume 193, number 2: Antibody Responses to Hepatitis A Virus Vaccine in HIV-Infected Children with Evidence of Immunologic Reconstitution while Receiving Highly Active Antiretroviral Therapy — J Infect Dis Latest Issue
- Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients — Medical News Today RSS/XML Feed
Latest news from StratWire - Business of Healthcare NewsFeed:
- Alliance Names New COO
- NHCAA to Award Those Who Fight and Expose the Deadly Side of Health Care Fraud
- More Than 2 mln Cancer Patients Treated with BrainLAB m3 Shaped Beam Radiosurgery
- PA's Continuing Trend Towards Total Body Reconstruction Keeps Consumers Demanding Comprehensive Direct-To-Consumer-Education (DTCE )
- Dr Farzad Yaghouti of Global Laser Vision San Diego Wins 'Best Lasik Surgeon 2006'
- 1st Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Medical Mutual of OH Financial Investigator Wins Top Nat'l Fraud-Fighting Award
- Intelligent Medical Objects and Bond Technologies Sign Multi-year Agreement
- M-CARE's Medicaid Plan Recognized as One of the Top Health Plans by US News & World Report/NCQA
- Fitch: MCH rates 'A-' on bonds